Skip to content
StockMarketAgent

ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · Real-Time Price · USD
$9.83
+0.00 (0.0%)· Live
Market cap88.2M
Net income (ttm)-39.7M
EPS (ttm)$-22.6
Shares out9M
Volume33,260
Beta-0.18
Price target$42.7+334.1%
Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm)
-39.7M
EPS (ttm)
$-22.6
Market cap
88.2M
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—

Sector percentile context

Refreshed 2026-05-10 22:07 UTC
Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-521.6
P25 n/aP50 n/aP75 n/a
ROIC-325.6
P25 n/aP50 n/aP75 n/a
Benchmarks · 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a

All PMN indicators

Market & fundamental data
Available fields
167
Groups with data
11
Currency
USD
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001374339
Company name
ProMIS Neurosciences, Inc.
Country
Canada
Country code
US
Cusip
74346M406
Employees
11
Employees Change
3%
Employees Change Percent
37.5
Enterprise value
$82M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
CA74346M5054
Last refreshed
2026-05-10
Market cap
$88.2M
Market cap category
Micro-Cap
Price
$9.83
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
PMN
Website
https://www.promisneurosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

2
MetricValue
Earnings Yield
-45.06%
FCF yield
-31.9%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Gross Profit
$-33.4M
Net Income
$-39.7M
Net Income Growth Years
0%
Profit Per Employee
$-3.6M
ROA
-176.5
Roa5y
-97.99
ROCE
3,226.5
ROE
-521.6
Roe5y
-566.7
ROIC
-325.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr10y
-17.65%
Cagr1y
-29.74%
Cagr3y
-60.66%
Cagr5y
-46.23%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

14
MetricValue
Assets
$9.2M
Cash
$6.2M
Current Assets
$9.2M
Current Liabilities
$10.4M
Equity
$-1.3M
Liabilities
$10.4M
Long Term Assets
$0
Long Term Liabilities
$29,182
Net Cash
$6.2M
Net Cash By Market Cap
$6.98
Net Cash Growth
-53.84%
Tangible Book Value
$-1.3M
Tangible Book Value Per Share
$-0.58
WACC
3.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
0.88
Net Working Capital
$-7.4M
Quick ratio
0.59
Working Capital
$-1.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-65.98%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-85.66%
1Y total return
-29.72%
200-day SMA
12.57
3Y total return
-93.91%
50-day SMA
15.06
50-day SMA vs 200-day SMA
50over200
5Y total return
-95.5%
All Time High
1,050
All Time High Change
-99.06%
All Time High Date
2017-12-28
All Time Low
6.27
All Time Low Change
56.78%
All Time Low Date
2025-11-28
ATR
1.02
Beta
-0.18
Beta1y
-0.13
Beta2y
0.12
Ch YTD
44.03
High
10.19
High52
39.75
High52 Date
2025-07-21
High52ch
-75.27%
Low
9.31
Low52
6.27
Low52 Date
2025-11-28
Low52ch
56.78%
Ma50ch
-34.72%
Price vs 200-day SMA
-21.79%
RSI
30.66
RSI Monthly
37.09
RSI Weekly
42.44
Sharpe ratio
0.41x
Sortino ratio
1.09
Total Return
-65.98%
Tr YTD
44.03
Tr1m
-9.65%
Tr1w
-10.72%
Tr3m
-22.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Analyst Count
3
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-1.58
Operating Income
$-39.7M
Price target
$42.67
Price Target Change
$334

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
4,604,032%
Float Percent
51.34%
Shares Insiders
11.51%
Shares Institutions
23.06%
Shares Out
8,967,693
Shares Qo Q
31.97%
Shares Yo Y
65.98%
Short Float
3%
Short Ratio
3.52
Short Shares
1.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
$-29M
Average Volume
41,620.65x
Bv Per Share
-0.58
Ch10y
-85.66
Ch1m
-9.65
Ch1w
-10.72
Ch1y
-29.73
Ch3m
-22.78
Ch3y
-93.91
Ch5y
-95.5
Ch6m
3.75
Change
0%
Change From Open
-1.21
Close
9.83
Days Gap
1.22
Dollar Volume
326,945.8
Earnings Date
2026-05-13
Earnings Time
bmo
EBIT
$-39.7M
EPS
$-22.61
F Score
1
FCF
$-28.1M
FCF EV Yield
-34.29x
FCF Per Share
$-3.14
Financing CF
20,944,670
Fiscal Year End
December
Founded
2,004
Investing CF
-702
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-25
Last Report Date
2025-12-31
Last Split Date
2025-11-28
Last Split Type
Reverse
Last10k Filing Date
2026-03-25
Ma150
12.12
Ma150ch
-18.86%
Ma20
11.2
Ma20ch
-12.22%
Net CF
-7,174,611
Next Earnings Date
2026-05-22
Open
9.95
Optionable
No
Position In Range
59.09
Post Close
9.83
Postmarket Change Percent
3.66
Postmarket Price
$10.19
Price Date
2026-05-08
Relative Volume
0.8x
Share Based Comp
857,628
Tr6m
3.75%
Volume
33,260

Deeper analysis on PMN

14 sections in the full report · jump straight to what you need
Forecast
Bull, base, and bear cases with expected-return framing.
→
Valuation
Fair-value bridge, DCF, owner earnings, and peer multiples.
→
Sensitivity
Cost-of-equity and terminal-growth stress table.
→
Risks
Kill scenarios, soft-pass flags, and downside catalysts.
→
Earnings
Next earnings setup and beat / inline / miss thresholds.
→
Position sizing
Entry, exit, conviction, and quarterly monitoring rules.
→
Financials
Revenue, margins, cash flow, and balance-sheet context.
→
Peers
Relative valuation and profitability against the cohort.
→
Moat
Economic-profit evidence and competitive advantage risk.
→
Industry cycle
Sector phase, capital cycle, and secular tailwinds.
→
Scorecard
Six-factor overlay and 9-category weighted scorecard.
→
Recommendation
Final action, action steps, opportunity, and biggest risk.
→
Perspectives
Growth, value, and income investor reads.
→
Archive
Prior monthly reports and rating changes.
→

Frequently asked questions

About this PMN report
What is the current PMN stock rating?
ProMIS Neurosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.
Where can I read the full PMN analysis?
The full report lives at /stocks/PMN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.
What fair-value range is used for PMN?
The latest report frames PMN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.
How often is the PMN page updated?
The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.